Chennai, Bharat – October 16, 2024 – Biodimension Technology Private Limited, a state of the art deep tech startup fascinated by human tissue and organ building, has effectively closed a ₹121 lakh investment spherical led through Campus Angels Network. This funding will boost up Biodimension’s undertaking to revolutionize the healthcare and pharmaceutical industries with cutting edge tissue fashions that allow extra environment friendly, moral, and human-relevant trying out for drug and beauty protection.
Based in 2021 through Manoj Kumar Sampath (CEO), Ranjith Kumar Velusamy (Prominent Innovation Officer), and Pradeep Arunachalam (Prominent Running Officer), Biodimension Generation has abruptly emerged as a pacesetter in biofabrication generation. The corporate develops purposeful replicas of human tissues to grant as a platform for drug, chemical, and beauty trying out. Their merchandise lend a moral backup to animal trying out, addressing vital demanding situations in pharmaceutical R&D and assembly the rising world call for for cruelty-free trying out forms.
Management Insights
Manoj Kumar, Co-Founder & CEO of Biodimension Generation, shared, “This funding marks a pivotal moment in our journey to redefine drug testing and healthcare innovation. With the support of Campus Angels Network, we are now positioned to scale our operations and expand the reach of our human tissue models. Our goal is to provide pharmaceutical and cosmetic industries with advanced testing platforms that offer more reliable, human-relevant data.”
Chandran Krishnan, Managing Director & CEO of Campus Angels Community, emphasised, “Biodimension’s innovative approach to biofabrication aligns perfectly with our philosophy of supporting deep tech startups that have a transformative impact. Their human tissue models not only offer a sustainable alternative to animal testing but also have the potential to greatly enhance the accuracy of pharmaceutical research and product testing. We are thrilled to partner with them on this exciting journey.”
Strategic Expansion
The investment will probably be applied to improve Biodimension’s cleanroom amenities, ramp up product building, and enlarge advertising efforts to extend adoption of its tissue fashions. This funding will additional solidify Biodimension’s place as a pacesetter within the abruptly rising non-animal trying out marketplace, positioning it for long-term expansion and luck in each the pharmaceutical and beauty industries.
About Biodimension Generation
Biodimension Generation is a biotechnology corporate incubated through Vellore Institute of Technology TBI and Sastra ABLEST. The corporate develops human tissue fashions the usage of complicated biofabrication applied sciences, offering a platform for extra moral and correct trying out in drug building, cosmetics, and alternative industries.
+ There are no comments
Add yours